These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 27816806)
21. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark. Jensen HK Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167 [TBL] [Abstract][Full Text] [Related]
23. The Genetic Spectrum of Familial Hypercholesterolemia (FH) in the Iranian Population. Fairoozy RH; Futema M; Vakili R; Abbaszadegan MR; Hosseini S; Aminzadeh M; Zaeri H; Mobini M; Humphries SE; Sahebkar A Sci Rep; 2017 Dec; 7(1):17087. PubMed ID: 29213121 [TBL] [Abstract][Full Text] [Related]
24. Spectrum of mutations of familial hypercholesterolemia in the 22 Arab countries. Alhababi D; Zayed H Atherosclerosis; 2018 Dec; 279():62-72. PubMed ID: 30415195 [TBL] [Abstract][Full Text] [Related]
25. Mutational analysis of the LDLR gene in a cohort of Colombian families with familial hypercholesterolemia. López G; Bernal LM; Gelvez N; Gómez LF; Nova A; Sánchez AI; Tamayo ML Atherosclerosis; 2018 Oct; 277():434-439. PubMed ID: 30270082 [TBL] [Abstract][Full Text] [Related]
26. Effect of mutations in LDLR and PCSK9 genes on phenotypic variability in Tunisian familial hypercholesterolemia patients. Slimani A; Jelassi A; Jguirim I; Najah M; Rebhi L; Omezzine A; Maatouk F; Hamda KB; Kacem M; Rabès JP; Abifadel M; Boileau C; Rouis M; Slimane MN; Varret M Atherosclerosis; 2012 May; 222(1):158-66. PubMed ID: 22417841 [TBL] [Abstract][Full Text] [Related]
27. Phenotypical, Clinical, and Molecular Aspects of Adults and Children With Homozygous Familial Hypercholesterolemia in Iberoamerica. Alves AC; Alonso R; Diaz-Diaz JL; Medeiros AM; Jannes CE; Merchan A; Vasques-Cardenas NA; Cuevas A; Chacra AP; Krieger JE; Arroyo R; Arrieta F; Schreier L; Corral P; Bañares VG; Araujo MB; Bustos P; Asenjo S; Stoll M; Dell'Oca N; Reyes M; Ressia A; Campo R; Magaña-Torres MT; Metha R; Aguilar-Salinas CA; Ceballos-Macias JJ; Morales ÁJR; Mata P; Bourbon M; Santos RD Arterioscler Thromb Vasc Biol; 2020 Oct; 40(10):2508-2515. PubMed ID: 32757650 [TBL] [Abstract][Full Text] [Related]
28. Genetic basis of index patients with familial hypercholesterolemia in Chinese population: mutation spectrum and genotype-phenotype correlation. Sun D; Zhou BY; Li S; Sun NL; Hua Q; Wu SL; Cao YS; Guo YL; Wu NQ; Zhu CG; Gao Y; Cui CJ; Liu G; Li JJ Lipids Health Dis; 2018 Nov; 17(1):252. PubMed ID: 30400955 [TBL] [Abstract][Full Text] [Related]
30. Novel PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Variants in Patients With Familial Hypercholesterolemia From Cape Town. Huijgen R; Blom DJ; Hartgers ML; Chemello K; Benito-Vicente A; Uribe KB; Behardien Z; Blackhurst DM; Brice BC; Defesche JC; de Jong AG; Jooste RJ; Solomon GAE; Wolmarans KH; Hovingh GK; Martin C; Lambert G; Marais AD Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):934-943. PubMed ID: 33147992 [TBL] [Abstract][Full Text] [Related]
31. Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor): Implications for the Efficacy of Evolocumab. Thedrez A; Blom DJ; Ramin-Mangata S; Blanchard V; Croyal M; Chemello K; Nativel B; Pichelin M; Cariou B; Bourane S; Tang L; Farnier M; Raal FJ; Lambert G Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):592-598. PubMed ID: 29284604 [TBL] [Abstract][Full Text] [Related]
32. Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia. Khera AV; Won HH; Peloso GM; Lawson KS; Bartz TM; Deng X; van Leeuwen EM; Natarajan P; Emdin CA; Bick AG; Morrison AC; Brody JA; Gupta N; Nomura A; Kessler T; Duga S; Bis JC; van Duijn CM; Cupples LA; Psaty B; Rader DJ; Danesh J; Schunkert H; McPherson R; Farrall M; Watkins H; Lander E; Wilson JG; Correa A; Boerwinkle E; Merlini PA; Ardissino D; Saleheen D; Gabriel S; Kathiresan S J Am Coll Cardiol; 2016 Jun; 67(22):2578-89. PubMed ID: 27050191 [TBL] [Abstract][Full Text] [Related]
33. Independent Severe Cases of Heterozygous Familial Hypercholesterolemia Caused by the W483X and Novel W483G Mutations in the Low-Density Lipoprotein Receptor Gene That Were Clinically Diagnosed as Homozygous Cases. Cheng S; Wu Y; Wen W; An M; Gao Y; Wang L; Han X; Shang H Genet Test Mol Biomarkers; 2019 Jun; 23(6):401-408. PubMed ID: 31161821 [No Abstract] [Full Text] [Related]
34. Proprotein convertase subtilisin/kexin 9 V4I variant with LDLR mutations modifies the phenotype of familial hypercholesterolemia. Ohta N; Hori M; Takahashi A; Ogura M; Makino H; Tamanaha T; Fujiyama H; Miyamoto Y; Harada-Shiba M J Clin Lipidol; 2016; 10(3):547-555.e5. PubMed ID: 27206942 [TBL] [Abstract][Full Text] [Related]
35. The study of familial hypercholesterolemia in Italy: A narrative review. Bertolini S; Pisciotta L; Fasano T; Rabacchi C; Calandra S Atheroscler Suppl; 2017 Oct; 29():1-10. PubMed ID: 28965614 [TBL] [Abstract][Full Text] [Related]
36. Targeted Genetic Analysis in a Chinese Cohort of 208 Patients Related to Familial Hypercholesterolemia. Wang H; Yang H; Liu Z; Cui K; Zhang Y; Zhang Y; Zhao K; Yin K; Li W; Zhou Z J Atheroscler Thromb; 2020 Dec; 27(12):1288-1298. PubMed ID: 32759540 [TBL] [Abstract][Full Text] [Related]
37. [Genotype-phenotype analysis of a homozygous familial hypercholesterolemia pedigree]. Wang DY; Zhang YM; Che FY; Chu JP; Zhang LY; Li H; Liu BL; Yao ZY; Zhao YW Zhonghua Er Ke Za Zhi; 2020 Feb; 58(2):101-106. PubMed ID: 32102145 [No Abstract] [Full Text] [Related]
38. Genetic diagnosis of familial hypercholesterolaemia using a rapid biochip array assay for 40 common LDLR, APOB and PCSK9 mutations. Martin R; Latten M; Hart P; Murray H; Bailie DA; Crockard M; Lamont J; Fitzgerald P; Graham CA Atherosclerosis; 2016 Nov; 254():8-13. PubMed ID: 27680772 [TBL] [Abstract][Full Text] [Related]
39. Establishing the Mutational Spectrum of Hungarian Patients with Familial Hypercholesterolemia. Madar L; Juhász L; Szűcs Z; Kerkovits L; Harangi M; Balogh I Genes (Basel); 2022 Jan; 13(1):. PubMed ID: 35052492 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of clinical diagnosis criteria of familial ligand defective apoB 100 and lipoprotein phenotype comparison between LDL receptor gene mutations affecting ligand-binding domain and the R3500Q mutation of the apoB gene in patients from a South European population. Ejarque I; Real JT; Martinez-Hervas S; Chaves FJ; Blesa S; Garcia-Garcia AB; Millan E; Ascaso JF; Carmena R Transl Res; 2008 Mar; 151(3):162-7. PubMed ID: 18279815 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]